Clinical Trials Logo

Clinical Trial Summary

To evaluate safety and efficacy of AIV001 treatment on low-risk basal cell carcinoma.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04470726
Study type Interventional
Source AiViva BioPharma, Inc.
Contact
Status Completed
Phase Phase 1/Phase 2
Start date August 18, 2020
Completion date July 28, 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04552990 - Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma Phase 2
Active, not recruiting NCT03573401 - Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). Phase 3
Completed NCT03012009 - Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial N/A
Completed NCT02270645 - Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser N/A
Completed NCT00469417 - Metvix PDT Versus Cryotherapy in Patients With Primary Superficial Basal Cell Carcinoma Phase 3
Recruiting NCT05381597 - 5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer Phase 2/Phase 3
Terminated NCT00994240 - Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC N/A
Completed NCT00604890 - Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma Phase 1/Phase 2
Completed NCT00189306 - Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream Phase 3
Recruiting NCT05157763 - A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma Phase 1/Phase 2
Recruiting NCT04744935 - Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma N/A
Completed NCT05628714 - A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma
Completed NCT00432185 - To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC Phase 2
Recruiting NCT01491711 - Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Phase 4
Completed NCT01325688 - PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities Phase 2
Recruiting NCT05713760 - Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults Phase 2